These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7761720)

  • 21. Oral malignant melanoma: the amsterdam experience.
    Meleti M; Leemans CR; Mooi WJ; van der Waal I
    J Oral Maxillofac Surg; 2007 Nov; 65(11):2181-6. PubMed ID: 17954312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural history of invasive cutaneous melanoma in Styria, Austria 2001-2003.
    Richtig E; Gerger A; Berghold A; Schwantzer G; Ott A; Kerl H; Smolle J
    J Dtsch Dermatol Ges; 2007 Apr; 5(4):293-9. PubMed ID: 17376093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical stages of cutaneous malignant melanoma in Bulgaria.
    Troyanova P; Valerianova Z; Danon S
    Neoplasma; 2000; 47(4):257-60. PubMed ID: 11043833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is superficial spreading melanoma still the most common form of malignant melanoma?
    Forman SB; Ferringer TC; Peckham SJ; Dalton SR; Sasaki GT; Libow LF; Elston DM
    J Am Acad Dermatol; 2008 Jun; 58(6):1013-20. PubMed ID: 18485983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
    Nahabedian MY; Tufaro AP; Manson PN
    Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variations in management of stage I to stage III cutaneous melanoma: a population-based study of clinical practices in France.
    Grange F; Vitry F; Granel-Brocard F; Lipsker D; Aubin F; Hédelin G; Dalac S; Truchetet F; Michel C; Batard ML; Baury B; Halna JM; Schmutz JL; Delvincourt C; Reuter G; Dalle S; Bernard P; Danzon A
    Arch Dermatol; 2008 May; 144(5):629-36. PubMed ID: 18490589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females: predictors of survival.
    Ragnarsson-Olding BK; Nilsson BR; Kanter-Lewensohn LR; Lagerlöf B; Ringborg UK
    Cancer; 1999 Oct; 86(7):1285-93. PubMed ID: 10506715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors.
    Lindholm C; Andersson R; Dufmats M; Hansson J; Ingvar C; Möller T; Sjödin H; Stierner U; Wagenius G;
    Cancer; 2004 Nov; 101(9):2067-78. PubMed ID: 15372475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
    Marghoob AA; Koenig K; Bittencourt FV; Kopf AW; Bart RS
    Cancer; 2000 Feb; 88(3):589-95. PubMed ID: 10649252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of ulceration in stages I to III cutaneous melanoma as staged by the American Joint Committee on Cancer Staging System: an analysis of the German Central Malignant Melanoma Registry.
    Eigentler TK; Buettner PG; Leiter U; Garbe C;
    J Clin Oncol; 2004 Nov; 22(21):4376-83. PubMed ID: 15514379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutaneous melanoma in the Maltese Islands: 2000-2004.
    Dalmas M; England K; Boffa MJ; Degaetano J; Gatt P
    Eur J Cancer; 2007 Jul; 43(10):1604-10. PubMed ID: 17532206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thick cutaneous malignant melanoma: a reappraisal of prognostic factors.
    Massi D; Borgognoni L; Franchi A; Martini L; Reali UM; Santucci M
    Melanoma Res; 2000 Apr; 10(2):153-64. PubMed ID: 10803716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variation in incidence and fatality of melanoma by season of diagnosis in new South Wales, Australia.
    Boniol M; Armstrong BK; Doré JF
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):524-6. PubMed ID: 16537711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003.
    Lasithiotakis KG; Leiter U; Gorkievicz R; Eigentler T; Breuninger H; Metzler G; Strobel W; Garbe C
    Cancer; 2006 Sep; 107(6):1331-9. PubMed ID: 16909413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acral lentiginous melanoma.
    Coleman WP; Loria PR; Reed RJ; Krementz ET
    Arch Dermatol; 1980 Jul; 116(7):773-6. PubMed ID: 7396539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology and prognosis of subungual melanoma in 34 Japanese patients.
    Kato T; Suetake T; Sugiyama Y; Tabata N; Tagami H
    Br J Dermatol; 1996 Mar; 134(3):383-7. PubMed ID: 8731657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Independent prognostic importance of vascular invasion in nodular melanomas.
    Straume O; Akslen LA
    Cancer; 1996 Sep; 78(6):1211-9. PubMed ID: 8826942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A ten-year analysis of demographic trends for cutaneous melanoma: analysis of 2501 cases treated at the University Department of Dermatology in Vienna (1990-1999).
    Kittler H; Binder M; Wolff K; Pehamberger H
    Wien Klin Wochenschr; 2001 Apr; 113(9):321-7. PubMed ID: 11388077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002.
    Coory M; Baade P; Aitken J; Smithers M; McLeod GR; Ring I
    Cancer Causes Control; 2006 Feb; 17(1):21-7. PubMed ID: 16411049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Symptoms and signs of primary melanoma: important indicators of Breslow depth.
    Negin BP; Riedel E; Oliveria SA; Berwick M; Coit DG; Brady MS
    Cancer; 2003 Jul; 98(2):344-8. PubMed ID: 12872355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.